Xarelto® Lawsuit Update: New Study Finds Bleeding Difficult to Stop for Some Anticoagulants, Including Xarelto®
A new study published in the August issue of the Journal of Neurosurgery found that internal bleeding associated with certain anticoagulants – including Xarelto® – is more difficult to stop in comparison to other blood thinning medications. The study discussed new guidelines on how to treat uncontrolled bleeding in the brain and pointed out that surgeons are faced with an extreme difficulty of treating brain hemorrhage patients who are taking certain direct Factor Xa inhibitor anticoagulant medications, such as Xarelto®. The study authors emphasize that when a patient suffers a bleed while taking warfarin, another blood thinning medication, the bleeding can be reversed by quickly administering vitamin K; however, direct Factor Xa inhibitors – such as Xarelto® – are within a newer class of anticoagulants that do not have a reversal agent.
In July 2011, Xarelto® was approved to prevent blood clots in patients undergoing knee and hip surgeries. The drug was then extended to patients with irregular heartbeats and deadly leg and lung blood clots. The ISMP reports that in 2013, the U.S. Food and Drug Administration (FDA) reported receiving 680 serious adverse event reports from individuals who alleged to have suffered adverse events while taking the anticoagulant drug Xarelto® (rivaroxaban). The FDA’s Adverse Event Reporting System (FAERS) remains the cornerstone of post-market safety surveillance, the mechanism through which most significant drug risks are detected once a drug has been approved and is available on the market.
Last year, Johnson & Johnson alone brought in approximately $847 Million in Xarelto® sales. The current market for blood thinning medications, including Xarelto®, is estimated to be worth $10 Billion. The Germany-based pharmaceutical company, Bayer, is still selling Xarelto® in Europe. It is estimated that sales could reach around 3.5 Euros annually.
If you or a loved one has suffered serious injuries after using Xarelto®, please contact the attorneys at Schlichter, Bogard & Denton, LLP toll-free at 1-800-873-5297 for your confidential and free consultation.
The choice of a lawyer is an important decision and should not be based solely on advertisements.